Export Leadership AryoGen Pharmed has been named a National Exemplary Exporter for 2023, underscoring its established international trade capabilities and reliability as a manufacturing partner. This recognition signals potential for international collaborations such as contract manufacturing, exclusive distribution rights, or co development deals in new regional markets.

Financial Scale With annual revenue in the range of $500 million to $1 billion and a 201-500 employee workforce, AryoGen demonstrates sufficient scale to support long term manufacturing contracts, toll manufacturing, and capacity expansion projects for complex biologics.

Strong Pipeline AryoGen emphasizes high quality biopharmaceutical technologies and maintains an active pipeline, creating opportunities for co development, technology licensing, and exclusive manufacturing rights to accelerate product launches.

Regional Advantage Located on Karadj Road in Alborz province, AryoGen could serve as a regional manufacturing hub with cost efficiencies and logistics advantages for markets in the Middle East and Central Asia, inviting regional supply agreements, toll manufacturing, and co manufacturing partnerships.

Global Health Alignment AryoGen's commitment to improving global health and its stated willingness to share improvements positions it well for partnerships with NGOs, government programs, and public private initiatives that seek responsible manufacturers, grant opportunities, or strategic alliances around biosimilars and life saving therapies.